Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The possible "calming effect" of subchronic supplementation of a standardised phospholipid carrier-based Melissa officinalis L. extract in healthy adults with emotional distress and poor sleep conditions: results from a prospective, randomised, double-blinded, placebo-controlled clinical trial.
Bano A, Hepsomali P, Rabbani F, Farooq U, Kanwal A, Saleem A, Bugti AA, Khan AA, Khalid Z, Bugti M, Mureed S, Khan S, Ujjan ID, Şahin S, Kara M, Khan A. Bano A, et al. Among authors: ujjan id. Front Pharmacol. 2023 Oct 19;14:1250560. doi: 10.3389/fphar.2023.1250560. eCollection 2023. Front Pharmacol. 2023. PMID: 37927585 Free PMC article.
Quercetin Phytosome® as a potential candidate for managing COVID-19.
DI Pierro F, Khan A, Bertuccioli A, Maffioli P, Derosa G, Khan S, Khan BA, Nigar R, Ujjan I, Devrajani BR. DI Pierro F, et al. Minerva Gastroenterol (Torino). 2021 Jun;67(2):190-195. doi: 10.23736/S2724-5985.20.02771-3. Epub 2020 Oct 5. Minerva Gastroenterol (Torino). 2021. PMID: 33016666 Free article. Review.
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study.
Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, Altaf N, Zahid M, Ujjan ID, Nigar R, Khushk MI, Phulpoto M, Lail A, Devrajani BR, Ahmed S. Di Pierro F, et al. Among authors: ujjan id. Int J Gen Med. 2021 Jun 8;14:2359-2366. doi: 10.2147/IJGM.S318720. eCollection 2021. Int J Gen Med. 2021. PMID: 34135619 Free PMC article. Clinical Trial.
Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.
Haroon MZ, Farooq U, Ashraf S, Zeb S, Gillani SY, Malik S, Ali R, Irshad R, Mehmood Z, Abbas Y, Masood A, Ghafoor A, Khalil AT, Asif H, Khan S, Ujjan ID, Nigar R, Livingstone S, Pascual-Figal DA, Togni S, Allergini P, Riva A, Khan A. Haroon MZ, et al. Among authors: ujjan id. J Physiol Pharmacol. 2022 Jun;73(3). doi: 10.26402/jpp.2022.3.09. Epub 2022 Oct 22. J Physiol Pharmacol. 2022. PMID: 36302537 Free article. Clinical Trial.
26 results